Citations (4)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Chenyu Sun, Scott Lowe, Shaodi Ma, Rachel Bentley, Zhen Zhou, Ce Cheng & Qin Zhou. (2022) CCNB2 expression correlates with worse outcomes in breast cancer patients: a pooled analysis. Women & Health 62:7, pages 655-663.
Read now
Read now
Articles from other publishers (3)
Xiao Meng, Dong Liu & Yan Guan. (2023) Advances in the application of label‐free quantitative proteomics techniques in malignancy research. Biomedical Chromatography 37:7.
Crossref
Crossref
Ying Shan, Banyun Mao, Ying Jin, Yan You, Yongxue Wang, Keng Shen & Lei Li. (2023) Expression of DDB1 is associated with subtypes of epithelial ovarian cancer and predicts clinical outcomes. Tissue and Cell 82, pages 102072.
Crossref
Crossref
Lei Zhang, Bin LiuJianzhi Su. (2023) CCNB2 as a potential biomarker of bladder cancer via the high throughput technology. Medicine 102:6, pages e32825.
Crossref
Crossref